Novonesis (Novozymes) A/S (NSIS-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novonesis (Novozymes) A/S (NSIS-B) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr466.58 Million ≈ $73.00 Million USD) by net assets (Dkr10.74 Billion ≈ $1.68 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novonesis (Novozymes) A/S - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Novonesis (Novozymes) A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Novonesis (Novozymes) A/S (NSIS-B) financial obligations for a breakdown of total debt and financial obligations.
Novonesis (Novozymes) A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novonesis (Novozymes) A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
American Water Works
NYSE:AWK
|
0.070x |
|
Cathay Financial Holding Co Ltd Pref A
TW:2882A
|
0.052x |
|
Banco do Brasil S.A.
SA:BBAS3
|
0.201x |
|
Swiss Life Holding AG
SW:SLHN
|
0.186x |
|
Hyundai Electric & Energy Systems Co Ltd
KO:267260
|
0.116x |
|
Willis Towers Watson PLC
NASDAQ:WTW
|
0.096x |
|
LPL Financial Holdings Inc
NASDAQ:LPLA
|
0.124x |
|
KUAISHOU TECHNOLOGY CL.B
F:5Y0
|
N/A |
Annual Cash Flow Conversion Efficiency for Novonesis (Novozymes) A/S (2002–2024)
The table below shows the annual cash flow conversion efficiency of Novonesis (Novozymes) A/S from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Novonesis (Novozymes) A/S.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Dkr11.18 Billion ≈ $1.75 Billion |
Dkr1.02 Billion ≈ $159.57 Million |
0.091x | -68.46% |
| 2023-12-31 | Dkr14.35 Billion ≈ $2.25 Billion |
Dkr4.15 Billion ≈ $649.61 Million |
0.289x | +2.76% |
| 2022-12-31 | Dkr14.23 Billion ≈ $2.23 Billion |
Dkr4.01 Billion ≈ $626.77 Million |
0.282x | -15.39% |
| 2021-12-31 | Dkr12.21 Billion ≈ $1.91 Billion |
Dkr4.06 Billion ≈ $635.53 Million |
0.333x | -14.08% |
| 2020-12-31 | Dkr11.24 Billion ≈ $1.76 Billion |
Dkr4.36 Billion ≈ $681.37 Million |
0.387x | +39.12% |
| 2019-12-31 | Dkr11.48 Billion ≈ $1.80 Billion |
Dkr3.20 Billion ≈ $500.04 Million |
0.278x | -13.45% |
| 2018-12-31 | Dkr11.44 Billion ≈ $1.79 Billion |
Dkr3.68 Billion ≈ $575.61 Million |
0.322x | -10.80% |
| 2017-12-31 | Dkr11.27 Billion ≈ $1.76 Billion |
Dkr4.06 Billion ≈ $635.69 Million |
0.361x | +10.30% |
| 2016-12-31 | Dkr11.74 Billion ≈ $1.84 Billion |
Dkr3.84 Billion ≈ $600.80 Million |
0.327x | +13.52% |
| 2015-12-31 | Dkr11.59 Billion ≈ $1.81 Billion |
Dkr3.34 Billion ≈ $522.41 Million |
0.288x | -28.20% |
| 2014-12-31 | Dkr11.28 Billion ≈ $1.76 Billion |
Dkr4.53 Billion ≈ $707.97 Million |
0.401x | +70.80% |
| 2013-12-31 | Dkr11.07 Billion ≈ $1.73 Billion |
Dkr2.60 Billion ≈ $406.63 Million |
0.235x | -18.52% |
| 2012-12-31 | Dkr9.57 Billion ≈ $1.50 Billion |
Dkr2.76 Billion ≈ $431.51 Million |
0.288x | -6.11% |
| 2011-12-31 | Dkr8.82 Billion ≈ $1.38 Billion |
Dkr2.71 Billion ≈ $423.84 Million |
0.307x | +3.51% |
| 2010-12-31 | Dkr7.84 Billion ≈ $1.23 Billion |
Dkr2.32 Billion ≈ $363.61 Million |
0.297x | -4.50% |
| 2009-12-31 | Dkr5.85 Billion ≈ $915.43 Million |
Dkr1.82 Billion ≈ $284.28 Million |
0.311x | -18.09% |
| 2008-12-31 | Dkr4.48 Billion ≈ $700.30 Million |
Dkr1.70 Billion ≈ $265.51 Million |
0.379x | -18.89% |
| 2007-12-31 | Dkr3.67 Billion ≈ $573.73 Million |
Dkr1.71 Billion ≈ $268.17 Million |
0.467x | +3.39% |
| 2006-12-31 | Dkr3.39 Billion ≈ $530.86 Million |
Dkr1.53 Billion ≈ $240.01 Million |
0.452x | +29.36% |
| 2005-12-31 | Dkr3.79 Billion ≈ $593.60 Million |
Dkr1.33 Billion ≈ $207.46 Million |
0.349x | +5.69% |
| 2004-12-31 | Dkr3.89 Billion ≈ $608.93 Million |
Dkr1.29 Billion ≈ $201.36 Million |
0.331x | +0.48% |
| 2003-12-31 | Dkr4.17 Billion ≈ $653.21 Million |
Dkr1.37 Billion ≈ $214.97 Million |
0.329x | +18.38% |
| 2002-12-31 | Dkr4.25 Billion ≈ $664.63 Million |
Dkr1.18 Billion ≈ $184.78 Million |
0.278x | -- |
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more